×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Contact Us
About Us
Subscribe
My Portfolio
My Account
Contact Us
About Us
Subscribe
My Account
My Portfolio
Logo

Insider Transactions by Ashish Mandelia

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
MRSNMersana Therapeutics, Inc.Ashish MandeliaVP, Chief Accounting OfficerJan 15, 2025Option/RSU Exercise-8,685-61,073Jan 17, 2025, 07:27 PM
MRSNMersana Therapeutics, Inc.Ashish MandeliaVP, Chief Accounting OfficerJan 16, 2025Sale$0.583,5542,06157,519Jan 17, 2025, 07:27 PM
MRSNMersana Therapeutics, Inc.Ashish MandeliaVP, Chief Accounting OfficerJan 14, 2025Option/RSU Exercise-4,783-54,179Jan 16, 2025, 05:25 PM
MRSNMersana Therapeutics, Inc.Ashish MandeliaVP, Chief Accounting OfficerJan 15, 2025Sale$0.631,7911,12852,388Jan 16, 2025, 05:25 PM
MRSNMersana Therapeutics, Inc.Ashish MandeliaVP, Chief Accounting OfficerJan 13, 2025Option/RSU Exercise-2,646-50,403Jan 15, 2025, 09:19 PM
MRSNMersana Therapeutics, Inc.Ashish MandeliaVP, Chief Accounting OfficerJan 14, 2025Sale$0.661,00766549,396Jan 15, 2025, 09:19 PM
MRSNMersana Therapeutics, Inc.Ashish MandeliaVP, Chief Accounting OfficerOct 01, 2024Option/RSU Exercise-30,000-55,973Oct 07, 2024, 05:47 PM
MRSNMersana Therapeutics, Inc.Ashish MandeliaVP, Chief Accounting OfficerOct 02, 2024Sale$2.004,8559,71051,118Oct 07, 2024, 05:47 PM
MRSNMersana Therapeutics, Inc.Ashish MandeliaVP, Chief Accounting OfficerOct 03, 2024Sale$1.963,3616,58847,757Oct 07, 2024, 05:47 PM
MRSNMersana Therapeutics, Inc.Ashish MandeliaVP, Chief Accounting OfficerJan 13, 2024Option/RSU Exercise-2,645-18,218Jan 17, 2024, 05:20 PM
MRSNMersana Therapeutics, Inc.Ashish MandeliaVP, Chief Accounting OfficerJan 14, 2024Option/RSU Exercise-4,783-23,001Jan 17, 2024, 05:20 PM
MRSNMersana Therapeutics, Inc.Ashish MandeliaVP, Chief Accounting OfficerJan 15, 2024Option/RSU Exercise-5,352-28,353Jan 17, 2024, 05:20 PM
MRSNMersana Therapeutics, Inc.Ashish MandeliaVP, Chief Accounting OfficerJan 16, 2024Sale$2.715,02513,61823,328Jan 17, 2024, 05:20 PM
MRSNMersana Therapeutics, Inc.Ashish MandeliaVP, ControllerJan 17, 2023Sale$5.743,57520,52013,619Jan 18, 2023, 08:20 PM
MRSNMersana Therapeutics, Inc.Ashish MandeliaVP, ControllerJan 14, 2023Option/RSU Exercise-4,784-11,842Jan 18, 2023, 08:20 PM
MRSNMersana Therapeutics, Inc.Ashish MandeliaVP, ControllerJan 15, 2023Option/RSU Exercise-5,352-17,194Jan 18, 2023, 08:20 PM
MRSNMersana Therapeutics, Inc.Ashish MandeliaVP, ControllerJan 14, 2022Option/RSU Exercise-5,353-5,353Jan 19, 2022, 06:19 PM
MRSNMersana Therapeutics, Inc.Ashish MandeliaVP, ControllerJan 18, 2022Sale$5.921,98211,7333,371Jan 19, 2022, 06:19 PM
MRSNMersana Therapeutics, Inc.Ashish MandeliaVP, ControllerJul 01, 2021Sale$13.6094212,8110Jul 02, 2021, 04:31 PM
MRSNMersana Therapeutics, Inc.Ashish MandeliaVP, ControllerJan 19, 2021Sale$21.2854511,5980Jan 20, 2021, 07:03 PM
MRSNMersana Therapeutics, Inc.Ashish MandeliaVP, ControllerJan 15, 2021Tax Payment (Shares)$21.092896,095545Jan 20, 2021, 07:03 PM
MRSNMersana Therapeutics, Inc.Ashish MandeliaVP, ControllerJan 15, 2021Option/RSU Exercise-834-834Jan 20, 2021, 07:03 PM
MRSNMersana Therapeutics, Inc.Ashish MandeliaVP, ControllerJan 04, 2021Sale$26.762476,6100Jan 06, 2021, 07:00 PM
MRSNMersana Therapeutics, Inc.Ashish MandeliaVP, ControllerJun 30, 2020Buy$4.873,38316,4753,383Jul 06, 2020, 04:15 PM
MRSNMersana Therapeutics, Inc.Ashish MandeliaVP, ControllerJul 02, 2020Sale$22.493,38376,0840Jul 06, 2020, 04:15 PM

Looking for more premium content?

We have created a comprehensive group of tools that allows you to estimate the intrinsic value of investments.

Subscribe